Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionStock Portfolio - Stock Portfolio
Latest Disclosed Ownership15,899 shares
Latest Disclosed Value $ 12,393,747
Stock Portfolio - Stock Portfolio ownership in LLY / Eli Lilly and Company

On August 25, 2025 - Stock Portfolio - Stock Portfolio filed a NPORT-P form disclosing ownership of 15,899 shares of Eli Lilly and Company (US:LLY) valued at $12,393,747 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 15,899 shares of Eli Lilly and Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $17,988,447 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-25 2025-06-30 NP Eli Lilly EC US5324571083 15,899 0 0.00 12,394 -5.62 1.6134
2025-05-28 2025-03-31 NP Eli Lilly EC US5324571083 15,899 -6,695 -29.63 13,131 -24.72 1.9022
2025-02-19 2024-12-31 NP Eli Lilly EC US5324571083 22,594 2,987 15.23 17,443 0.41 2.3352
2024-11-27 2024-09-30 NP Eli Lilly EC US5324571083 19,607 342 1.78 17,371 -0.41 2.3091
2024-08-20 2024-06-30 NP Eli Lilly EC US5324571083 19,265 -754 -3.77 17,442 12.00 2.4782
2024-05-28 2024-03-31 NP Eli Lilly EC US5324571083 20,019 -4,781 -19.28 15,574 7.73 2.3232
2024-02-02 2023-12-31 NP Eli Lilly EC US5324571083 24,800 -6,100 -19.74 14,456 -12.90 2.4318
2023-11-29 2023-09-30 NP Eli Lilly EC US5324571083 30,900 -700 -2.22 16,597 12.00 2.9687
2023-08-22 2023-06-30 NP Eli Lilly EC US5324571083 31,600 -2,500 -7.33 14,820 26.55 2.5316
2023-05-26 2023-03-31 NP Eli Lilly EC US5324571083 34,100 6,600 24.00 11,711 16.40 2.0977
2023-03-01 2022-12-31 NP Eli Lilly EC US5324571083 27,500 -3,000 -9.84 10,061 2.01 1.8291
2022-11-28 2022-09-30 NP Eli Lilly EC US5324571083 30,500 1,600 5.54 9,862 5.25 1.8054
2022-08-22 2022-06-30 NP Eli Lilly EC US5324571083 28,900 -13,500 -31.84 9,370 -22.83 1.5762
2022-05-27 2022-03-31 NP Eli Lilly EC US5324571083 42,400 -9,200 -17.83 12,142 -14.80 1.6646
2022-02-28 2021-12-31 NP Eli Lilly EC US5324571083 51,600 51,600 14,253 1.6358
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.